Amprenavir/Ritonavir, Saquinavir/Ritonavir or Efavirenz in HIV-Infected Subjects Following Failure With Kaletra (ABT-378/Ritonavir) as Their First Protease Inhibitor Based HAART
Public ClinicalTrials.gov record NCT00038532. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open Label, Phase II Study of Amprenavir/Ritonavir, Saquinavir/Ritonavir or Efavirenz in HIV-Infected Subjects Following Failure With Kaletra (ABT-378/Ritonavir) as Their First Protease Inhibitor Based HAART
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to study amprenavir/ritonavir, saquinavir/ritonavir or efavirenz in HIV-infected patients following failure with Kaletra (ABT-378/ritonavir) as their first protease inhibitor based HAART.
Study identification
- NCT ID
- NCT00038532
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 24 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 2001 (Type not available)
- Primary completion
- Not listed
- Completion
- Not listed
- Last update posted
- Apr 1, 2008
Started 2001
United States locations
- U.S. sites
- 26
- U.S. states
- 15
- U.S. cities
- 23
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Phoenix Body Positive, Inc. | Phoenix | Arizona | 85006 | — |
| Paul J. Cimoch, M.D. | Fountain Valley | California | 92780 | — |
| AIDS Health Care Foundation - Research Center | Los Angeles | California | 90027 | — |
| Tower Infectious Diseases Medical Associates | Los Angeles | California | 90048 | — |
| 20th Avenue Medical Center Kaiser Permanente | Denver | Colorado | 80205 | — |
| University of Colorado Health Sciences Center | Denver | Colorado | 80262 | — |
| IDC Research Initiative | Altamonte Springs | Florida | 32701 | — |
| Gary J. Richmond, M.D. | Fort Lauderdale | Florida | 33316 | — |
| Associates in Research | Fort Myers | Florida | 33901 | — |
| University of Miami School of Medicine | Miami | Florida | 33136 | — |
| Infectious Disease Research Institute, Inc. | Tampa | Florida | 33614 | — |
| AIDS Research Consortium of Atlanta, Inc. | Atlanta | Georgia | 30308 | — |
| CORE Center | Chicago | Illinois | 60612 | — |
| Donna E. Sweet, M.D. | Wichita | Kansas | 67214 | — |
| David Parks, M.D. | St Louis | Missouri | 63139 | — |
| Saint Michael's Medical Center | Newark | New Jersey | 07102 | — |
| Howard A. Grossman, M.D. | New York | New York | 10011 | — |
| John B. Montana, M.D. | New York | New York | 10011 | — |
| State University of New York at Stony Brook | Stony Brook | New York | 11794-08153 | — |
| University of Cincinnati Medical Center | Cincinnati | Ohio | 45267-0405 | — |
| The Research & Education Group | Portland | Oregon | 97209 | — |
| Bornemann Internal Medicine | Reading | Pennsylvania | 19601 | — |
| David Wright, M.D. | Austin | Texas | 78705 | — |
| University of Texas Medical Branch | Galveston | Texas | 77555-0435 | — |
| Diversified Medical Practices, P.A. | Houston | Texas | 77027 | — |
| Hampton Roads Medical Specialists | Hampton | Virginia | 23666 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 28 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00038532, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 1, 2008 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00038532 live on ClinicalTrials.gov.